首页> 外国专利> Use of a gelatin matrix to ensure the functionality or to improve the quality of the use of (one or more) pharmaceutical or dietary supplement (s) for the treatment and / or prophylaxis of - but not limited to - mobility problems, bone diseases, connective tissue weakness, immune system weakness, regeneration after exercise and / or disease by inclusion of the active ingredients in selfs.

Use of a gelatin matrix to ensure the functionality or to improve the quality of the use of (one or more) pharmaceutical or dietary supplement (s) for the treatment and / or prophylaxis of - but not limited to - mobility problems, bone diseases, connective tissue weakness, immune system weakness, regeneration after exercise and / or disease by inclusion of the active ingredients in selfs.

机译：使用明胶基质以确保（一种或多种）药物或膳食补充剂用于治疗和/或预防（但不限于）行动不便，骨骼疾病，结缔组织无力，免疫系统无力，运动后再生和/或自身中含有有效成分的疾病。

页面导航

摘要
著录项
相似文献

摘要

Use of a gelatin matrix to ensure the functionality or to improve the quality of the use of (one or more) pharmaceutical or dietary supplement (s) for the treatment and / or prophylaxis of - but not limited to - mobility problems, bone diseases, connective tissue weakness, immune system weakness, regeneration after athletic Activation and / or illness by inclusion of the active substances in self.

机译：使用明胶基质来确保（一种或多种）药物或膳食补充剂用于治疗和/或预防（但不限于）行动不便，骨骼疾病，结缔组织无力，免疫系统无力，运动后再生激活和/或由于自身内含活性物质引起疾病。

著录项

公开/公告号DE102016002654A1

专利类型
公开/公告日2017-09-14

原文格式PDF
申请/专利权人 STEFANIE ALBER;
展开▼

申请/专利号DE20161002654
发明设计人 GLEICH ANMELDER;
展开▼

申请日2016-03-08
分类号A61K47/42;A61K38/01;A61P19;A61K31/401;A61K31/7004;A23L33/105;A23L33/28;A23L33/12;A23L33/175;A23L33/18;A23L33/17;A23L33/125;A61K36;
国家 DE
入库时间 2022-08-21 13:22:25

相似文献

专利
外文文献